Long-Term Oncological and Overall Outcomes of Percutaneous Radio Frequency Ablation in High Risk Surgical Patients With a Solitary Small Renal Mass

Journal of Urology

Volumn 180, Issue 2, 2008, Pages 499-504

  Levinson, Adam W ^a   Su, Li Ming ^a   Agarwal, Devesh ^a   Sroka, Myrna ^a   Jarrett, Thomas W ^b   Kavoussi, Louis R ^c   Solomon, Stephen B ^d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c North Shore Long Island Jewish Health System ^*  (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

carcinoma; catheter ablation; kidney; mortality; renal cell

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LIFE EXPECTANCY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; REOPERATION; SURGEON; SURGICAL PATIENT; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CATHETER ABLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 46749096673     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.04.031     Document Type: Article

References (20)

1. Jayson M., and Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51 (1998) 203
2. Sweeney J.P. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. Br J Urol 78 (1996) 351
3. Ahrar K. The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors. Curr Oncol Rep 6 (2004) 315
4. Zlotta A.R., Wildschutz T., Raviv G., Peny M.O., van Gansbeke D., Noel J.C., et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 11 (1997) 251
5. Varkarakis I.M., Allaf M.E., Inagaki T., Bhayani S.B., Chan D.Y., Su L.M., et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol 174 (2004) 456
6. Lewin J.S., Nour S.G., Connell C.F., Sulman A., Duerk J.L., Resnick M.I., et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology 232 (2004) 835
7. Arzola J., Baughman S.M., Bishoff J.T., and Hernandez J. Computed-tomography guided, resistance based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology 68 (2006) 983
8. Park S., Lotan Y., Cadeddu J.A., Anderson J.K., Matsumoto E.D., and Josephs S. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20 (2006) 569
9. Matin S.F., Ahrar K., Cadeddu J.A., Gervais D.A., McGovern F.J., Zagoria R.A., et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176 (2006) 1973
10. McDougal W.S., Gervais D.A., McGovern F.J., and Mueller P.R. Long-term followup of patients with renal cell carcinoma treated with radiofrequency ablation with curative intent. J Urol 174 (2005) 61
11. Fergany A.F., Hafez K.S., and Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163 (2000) 442
12. Hafez K.S., Fergany A.F., and Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162 (1999) 1930
13. Belldegrun A., Tsui K.H., deKernion J.B., and Smith R.B. Efficacy of nephron sparing surgery for renal cell carcinoma: analysis based on the 1997 tumor-node-metastasis staging system. J Clin Oncol 17 (1999) 2868
14. Moinzadeh A., Gill I.S., Finelli A., Kaouk J., and Desai M. Laparoscopic partial nephrectomy: 3-year followup. J Urol 175 (2006) 459
15. Gill I.S., Novick A.C., Meraney A.M., Chen R.N., Hobart M.G., Sung G.T., et al. Laparoscopic renal cryoablation in 32 patients. Urology 56 (2000) 748
16. Walther M.C., Shawker T.H., Libutti S.K., Lubensky I., Choyke P.L., Venzon D., et al. A phase 2 study of radiofrequency interstitial tissue ablation of localized renal tumors. J Urol 163 (2000) 1424
17. Allaf M.E., Varkarakis I.M., Bhayani S.B., Inagaki T., Kavoussi L.R., and Solomon S.B. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation-initial observations. Radiology 237 (2005) 366
18. Clark T.W., Millward S.F., Gervais D.A., Goldberg S.N., Grassi C.J., Kinney T.B., et al. Reporting standards for percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol 17 (2006) 1563
19. Goldberg S.N., Grassi C.J., Cardella J.F., Charboneau J.W., Dodd III G.D., Dupuy D.E., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Society of Interventional Radiology Technology Assessment Committee. J Vasc Interv Radiol 16 (2005) 765
20. Chawla S.N., Crispen P.L., Hanlon A.L., Greenberg R.E., Chen D.Y., and Uzzo R.G. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006) 425